Loss-of-function variants of the filaggrin gene are not major susceptibility factors for psoriasis vulgaris or psoriatic arthritis in German patients

Journal of Investigative Dermatology

Volumn 127, Issue 6, 2007, Pages 1367-1370

  Hüffmeier, Ulrike ^a   Traupe, Heiko ^b   Oji, Vinzenz ^b   Lascorz, Jesús ^a   Ständer, Markward ^c   Lohmann, Jörg ^d   Wendler, Jörg ^e   Burkhardt, Harald ^f   Reis, André ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c Paulinenkrankenhaus ^*  (Germany)

^d Psoriasis Rehabilitation Hospital   (Germany)

^e Rheumatologische Schwerpunktpraxis   (Germany)

^f GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FILAGGRIN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EPIDERMIS CELL; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC SUSCEPTIBILITY; GERMANY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS;

ARTHRITIS, PSORIATIC; EPIDERMIS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; MUTATION; PSORIASIS; RISK FACTORS; VARIATION (GENETICS);

EID: 34248585440     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700720     Document Type: Article

References (17)

1. Cookson WO, Ubhi B, Lawrence R, Abecasis GR, Walley AJ, Cox HE et al. (2001) Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 27:372-3
2. Ghadially R, Reed JT, Elias PM (1996) Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol 107:558-64
3. Helms C, Cao L, Krueger JG,Wijsman EM, Chamian F, Gordon D et al. (2003) A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet 35:349-56
4. Huffmeier U, Lascorz J, Traupe H, Bohm B, Schurmeier-Horst F, Stander M et al. (2005a) Systematic linkage disequilibrium analysis of SLC12A8 at PSORS5 confirms a role in susceptibility to psoriasis vulgaris. J Invest Dermatol 125:906-12
5. Huffmeier U, Reis A, Steffens M, Lascorz J, Bohm B, Lohmann J et al. (2006) Male restricted genetic association of variant R620W in PTPN22 with psoriatic arthritis. J Invest Dermatol 126:932-5
6. Huffmeier U, Traupe H, Burkhardt H, Schurmeier-Horst F, Lascorz J, Bohm B et al. (2005b) Lack of evidence for genetic association to RUNX1 binding site at PSORS2 in different German psoriasis cohorts. J Invest Dermatol 124:107-10
7. Kalinin AE, Kajava AV, Steinert PM (2002) Epithelial barrier function: assembly and structural features of the cornified cell envelope. Bioessays 24:789-800
8. Morar N, Bowcock AM, Harper JI, Cookson WO, Moffatt MF (2006) Investigation of the chromosome 17q25 PSORS2 locus in atopic dermatitis. J Invest Dermatol 126:603-6
9. Nickoloff BJ, Naidu Y (1994) Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 30:535-46
10. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP et al. (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38:441-6
11. Sator PG, Schmidt JB, Honigsmann H (2003) Comparison of epidermal hydration and skin surface lipids in healthy individuals and in patients with atopic dermatitis. J Am Acad Dermatol 48:352-8
12. Segre JA (2006) Epidermal barrier formation and recovery in skin disorders. J Clin Invest 116:1150-8
13. Smith FJ, Irvine AD, Terron-Kwiatkowski A, Sandilands A, Campbell LE, Zhao Y et al. (2006) Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 38:337-42
14. Stuart P, Nair RP, Abecasis GR, Nistor I, Hiremagalore R, Chia NV et al. (2006) Analysis of RUNX1 binding site and RAPTOR polymorphisms in psoriasis: no evidence for association despite adequate power and evidence for linkage. J Med Genet 43:12-7
15. van der Vleuten CJ, de Jong EM, van de Kerkhof PC (1996) Epidermal differentiation characteristics of the psoriatic plaque during treatment with calcipotriol. Arch Dermatol Res 288:366-72
16. Wood LC, Stalder AK, Liou A, Campbell IL, Grunfeld C, Elias PM et al. (1997) Barrier disruption increases gene expression of cytokines and the 55 kD TNF receptor in murine skin. Exp Dermatol 6:98-104
17. Zenz R, Eferl R, Kenner L, Florin L, Hummerich L, Mehic D et al. (2005) Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437:369-75